#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Corneal neovascularisation Cold type haemolytic anaemia Immunodeficiency congenital Ductal adenocarcinoma of pancreas Prodromal Alzheimer's disease Idiopathic inflammatory myopathy Colitis ulcerative Mitochondrial encephalomyopathy Haemophilia A with anti factor VIII Narcolepsy Loss of consciousness Spina bifida Haemophilia B with anti factor IX Aicardi-Goutieres syndrome Mycobacterium abscessus infection More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Diagnostics Soft tissue sarcoma – Diagnostics Pituitary-dependent Cushing’s syndrome – Life with Disease Hypereosinophilic syndrome – Basic Information Haemophilia A with anti factor VIII – Basic Information Tuberous sclerosis complex – Treatment Nodal marginal zone B-cell lymphoma – Life with Disease Proteus syndrome – Basic Information Leiomyosarcoma recurrent – Trials in Disease Myxofibrosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenobarbital Glycerol Rosuvastatin Altizide Olaparib AMG 732 Tropicamide INDAPAMIDE HEMIHYDRATE Evg321 Abc-31-116 Toldc Nomegestrol Acetate Bms-986408 Molgramostim D5-Ethyl-Beta-D-Glucuronide L-Arginine Hydrochloride Inotuzumab Ozogamicin Dornase Alfa ZIGAKIBART Neridronate Sodium More therapies…

    Learn about Your Condition

    Schizoaffective disorder Retinitis pigmentosa Bladder cancer stage III Dementia with Lewy bodies Neck pain Laparotomy Angiosarcoma non-metastatic Encephalopathy neonatal Bartonellosis Skin neoplasm excision Muscle hypertrophy Obstructive airways disorder Still's disease Colorectal adenoma Mixed dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephroblastoma
    Investigated Drugs:
    • Dactinomycin
    • Etoposide
    • Carboplatin
    Austria Belgium Czechia Denmark France Germany +5

  • Study on Pelacarsen for Slowing Calcific Aortic Valve Stenosis in Patients

    Recruiting

    2 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Czechia Denmark France Germany +4

  • Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glomerulonephritis minimal lesion
    • Focal segmental glomerulosclerosis
    • Alport’s syndrome
    Investigated Drugs:
    • Sparsentan
    Germany Italy The Netherlands Poland Spain Sweden

  • Study on BP1.7881 for Adults with Eosinophilic Esophagitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Bp1.7881A
    France Italy

  • Study on Dapagliflozin for Patients with Decompensated Liver Cirrhosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    • Hepatic cirrhosis
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Teclistamab
    • Lenalidomide
    Austria Belgium Czechia Denmark France Germany +7

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Glucose Monohydrate Ph. Eur.
    • Levocarnitine
    • Sodium S-Lactate Solution
    Denmark Germany Italy Spain Sweden

  • Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

    Recruiting

    2 1
    Investigated Diseases:
    • Indolent systemic mastocytosis
    Investigated Drugs:
    • 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
    Belgium Bulgaria France Germany Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Riliprubart Compared to Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Riliprubart
    Belgium Czechia Denmark France Germany Greece +7

  • Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Chlorphenamine Maleate
    • Allopurinol
    • Sulfamethoxazole
    Italy
Previous Page
1 … 12 13 14 15 16 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!